Evidence map›Paper›PMID 35881586›Full record

ArticlePloS one2022

Oncology provider experiences during the COVID-19 pandemic.

Hannah Arem, Jenna Moses, Larissa Nekhlyudov, Maureen Killackey, Beth Sieloff, Cindy Cisneros, Mandi L Pratt-Chapman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hannah AremHealthcare Delivery Research, Medstar Health Research Institute, Washington, DC, United States of America.ORCID 0000-0002-5734-0810
Jenna MosesDepartment of Epidemiology, George Washington University Milken Institute School of Public Health, Washington, DC, United States of America.
Larissa NekhlyudovGeorge Washington University Cancer Center, Community Advisory Board, Washington, DC, United States of America.
Maureen KillackeyGeorge Washington University Cancer Center, Community Advisory Board, Washington, DC, United States of America.
Beth SieloffGeorge Washington University Cancer Center, Community Advisory Board, Washington, DC, United States of America.
Cindy CisnerosGeorge Washington University Cancer Center, Community Advisory Board, Washington, DC, United States of America.
Mandi L Pratt-ChapmanSchool of Medicine and Health Sciences, George Washington University, Washington, DC, United States of America.ORCID 0000-0002-9303-7659
George Washington University · USBrigham and Women's Hospital · USMedStar Health · USMilken Institute · US

Funding

Clinical and Translational Science Institute at Childrens NationalUL1TR001876 · NCATS · CHILDREN'S RESEARCH INSTITUTE · PI BELL, MICHAEL J · 2016 to 2021
$25.6M
NCATS NIH HHS UL1 TR001876
6 · The paper itself

Abstract

purposeThe COVID-19 pandemic upended nearly all aspects of daily life and of medical care, placing a double burden of professional and personal concerns on those who provide medical care. We set out to assess the burden of the pandemic on provider outlook and understand how cancer survivorship providers experienced rapid changes to practice.

methodsWe distributed a survey through the American College of Surgeons Commission on Cancer (CoC) to its accredited organizations in mid-October 2020. We included questions on provider characteristics, changes in patient care practices resulting from the pandemic, worry about COVID-19, and concern about impact on cancer survivors.

resultsOf the n = 607 participants, three-quarters were female and three-quarters were White. Only 2.1% of participants reported having had COVID-19, but 43% reported anxiety about getting COVID-19 and over a quarter experienced sadness or depression, anxiety about the future, changes to sleep, difficulty concentrating, or social isolation. Approximately half of providers also expressed significant concern about progression of cancer in patients who experienced care delays or were afraid of accessing in-person care. In terms of changes to survivorship care, respondents reported changes to visitor policies, delays or cancellations, and efforts to reduce in-person visits.

conclusionsCOVID-19 has taken a significant toll on front-line healthcare professionals, including oncologists and cancer care allied health professionals. Findings support proactive mental health support of healthcare professionals as well as emergency preparedness to manage delays to care for cancer patients in the event of future unexpected pandemics.

Indexed as

COVID-19NeoplasmsOncologistsFemaleHumansMaleMedical OncologyPandemicsSARS-CoV-2

Identifiers

PMID35881586
PMCPMC9321423
OpenAlexW4288039984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.